Skip to content

Evaluate Dental Plaque Benefit of a Preventive Treatment Gel

A Clinical Study to Evaluate Anti-Plaque Benefit of a Gel in a Modified- 4 Day Plaque Model

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03546491
Enrollment
32
Registered
2018-06-06
Start date
2018-05-08
Completion date
2018-06-22
Last updated
2019-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Plaque

Brief summary

The objective of the study is to evaluate anti-plaque efficacy of a preventive treatment gel in a modified 4-day plaque model.

Interventions

DRUGPreventive Gel

0.4% Stannous Fluoride

DRUGMarketed Control

0.243% Sodium Fluoride

Sponsors

Procter and Gamble
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Provide written informed consent prior to participation and be given a signed copy of the informed consent form; * Be 18 years of age or older; * Agree not to participate in any other oral/dental product studies during the study; * Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed; * Agree to refrain from the use of any non-study oral hygiene products (subjects who are regular flossers will be allowed to floss during acclimation and wash-out periods); * Agree to use an oral hygiene product that contains stannous fluoride; * Agree to refrain from any form of non-specified oral hygiene during the treatment period, including the use of products such as floss, toothpicks for plaque removal, and chewing gum; * Agree to refrain from any oral hygiene, eating and drinking after 11:00 PM the evening before plaque measurements on Day 0 and Day 4 of the treatment periods; * Agree to return for all scheduled visits and follow study procedures; * Possess a minimum of 20 natural teeth with scorable facial and lingual surfaces, of which at least 4 are molars; and, * Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study.

Exclusion criteria

• Have a medical condition requiring pre-medication prior to dental procedures; * Have taken antibiotics within 2 weeks of the acclimation period or anticipate taking antibiotics at any time during the study; * Have a history of allergies or hypersensitivity to dyes or dentifrices that contain stannous fluoride; * Have removable or orthodontic appliances which interfere with obtaining 20 gradable teeth; * Have previously demonstrated an inability to comply with study visit requirements; * Have rampant caries, open or untreated caries, severe gingivitis or advanced periodontitis requiring prompt treatment; or, * Present with any disease or condition(s) that could be expected to interfere with examination procedures or the subject's safe completion of the study.

Design outcomes

Primary

MeasureTime frameDescription
Mean Turesky Modified Quigley-Hein Index at Day 4Day 4The Turesky Modified Quigley-Hein Index was scored on six surfaces (distobuccal, midbuccal, mesiobuccal, distolingual, midlingual and mesiolingual) to assess plaque on all gradable teeth. Whole mouth average plaque scores were calculated for each subject and tooth surfaces by totaling the scores and dividing by the number of gradable sites examined. the scoring criteria is below; (0) No Plaque; (1) Separate flecks of plaque at the cervical margin; (2) A thin, continuous band of plaque (up to 1 mm) at the cervical margin; (3) A band of plaque wider than 1 mm, but covering less than one third of the side of the crown of the tooth; (4) Plaque covering at least one third, but less than two thirds of the side of the crown of the tooth; (5) Plaque covering two thirds or more of the side of the crown of the tooth.

Secondary

MeasureTime frameDescription
Mean Turesky Modified Quigley-Hein Index at BaselineBaselineThe Turesky Modified Quigley-Hein Index was scored on six surfaces (distobuccal, midbuccal, mesiobuccal, distolingual, midlingual and mesiolingual) to assess plaque on all gradable teeth. Whole mouth average plaque scores were calculated for each subject and tooth surfaces by totaling the scores and dividing by the number of gradable sites examined. the scoring criteria is below; (0) No Plaque; (1) Separate flecks of plaque at the cervical margin; (2) A thin, continuous band of plaque (up to 1 mm) at the cervical margin; (3) A band of plaque wider than 1 mm, but covering less than one third of the side of the crown of the tooth; (4) Plaque covering at least one third, but less than two thirds of the side of the crown of the tooth; (5) Plaque covering two thirds or more of the side of the crown of the tooth.
Digital Plaque ImagingDay 4Total percent dental plaque area
Overall Baseline Mean Digital Plaque ImagingBaselineTotal percent dental plaque area

Countries

United States

Participant flow

Participants by arm

ArmCount
Overall Study
This was a controlled, examiner-blind, randomized, 2-treatment, 3-period cross-over 4-day partial brushing plaque study.
32
Total32

Baseline characteristics

CharacteristicOverall Study
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
32 Participants
Race/Ethnicity, Customized
Ethnicity
Asian
2 Participants
Race/Ethnicity, Customized
Ethnicity
Black or African American
5 Participants
Race/Ethnicity, Customized
Ethnicity
Not Reported
1 Participants
Race/Ethnicity, Customized
Ethnicity
White Caucasian
24 Participants
Region of Enrollment
United States
32 participants
Sex: Female, Male
Female
21 Participants
Sex: Female, Male
Male
11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 320 / 32
other
Total, other adverse events
8 / 326 / 32
serious
Total, serious adverse events
0 / 320 / 32

Outcome results

Primary

Mean Turesky Modified Quigley-Hein Index at Day 4

The Turesky Modified Quigley-Hein Index was scored on six surfaces (distobuccal, midbuccal, mesiobuccal, distolingual, midlingual and mesiolingual) to assess plaque on all gradable teeth. Whole mouth average plaque scores were calculated for each subject and tooth surfaces by totaling the scores and dividing by the number of gradable sites examined. the scoring criteria is below; (0) No Plaque; (1) Separate flecks of plaque at the cervical margin; (2) A thin, continuous band of plaque (up to 1 mm) at the cervical margin; (3) A band of plaque wider than 1 mm, but covering less than one third of the side of the crown of the tooth; (4) Plaque covering at least one third, but less than two thirds of the side of the crown of the tooth; (5) Plaque covering two thirds or more of the side of the crown of the tooth.

Time frame: Day 4

ArmMeasureValue (MEAN)Dispersion
Preventive GelMean Turesky Modified Quigley-Hein Index at Day 41.83 score on a scaleStandard Error 0.055
Marketed ControlMean Turesky Modified Quigley-Hein Index at Day 41.96 score on a scaleStandard Error 0.055
Secondary

Digital Plaque Imaging

Total percent dental plaque area

Time frame: Day 4

ArmMeasureValue (MEAN)Dispersion
Preventive GelDigital Plaque Imaging8.14 percentage of plaque areaStandard Error 0.871
Marketed ControlDigital Plaque Imaging10.95 percentage of plaque areaStandard Error 0.871
Secondary

Mean Turesky Modified Quigley-Hein Index at Baseline

The Turesky Modified Quigley-Hein Index was scored on six surfaces (distobuccal, midbuccal, mesiobuccal, distolingual, midlingual and mesiolingual) to assess plaque on all gradable teeth. Whole mouth average plaque scores were calculated for each subject and tooth surfaces by totaling the scores and dividing by the number of gradable sites examined. the scoring criteria is below; (0) No Plaque; (1) Separate flecks of plaque at the cervical margin; (2) A thin, continuous band of plaque (up to 1 mm) at the cervical margin; (3) A band of plaque wider than 1 mm, but covering less than one third of the side of the crown of the tooth; (4) Plaque covering at least one third, but less than two thirds of the side of the crown of the tooth; (5) Plaque covering two thirds or more of the side of the crown of the tooth.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Preventive GelMean Turesky Modified Quigley-Hein Index at Baseline2.19 score on a scaleStandard Error 0.07
Marketed ControlMean Turesky Modified Quigley-Hein Index at Baseline2.22 score on a scaleStandard Error 0.07
Secondary

Overall Baseline Mean Digital Plaque Imaging

Total percent dental plaque area

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Preventive GelOverall Baseline Mean Digital Plaque Imaging6.57 percentage of plaque areaStandard Error 1.18
Marketed ControlOverall Baseline Mean Digital Plaque Imaging7.29 percentage of plaque areaStandard Error 1.18

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026